Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease

References

• Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev. 2001;10(2):101–106.
   PubMed Web of Science ®Google Scholar
• Siracusano S, Silvestri T, Casotto D. Sexually transmitted diseases: epidemiological and clinical aspects in adults. Urologia. 2014;81(4):200–208.
   PubMedGoogle Scholar
• Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer. 2005;15(5):727–746.
   PubMed Web of Science ®Google Scholar
• Aral SO, Holmes KK. Social and behavioral determinants of epidemiology of STDs: industrialized and developing countries. In: Holmes KK, Sparling PF, Mardh P, eds. Sexually transmitted diseases. New York, NY: McGraw-Hill; 1999. p. 39–76.
   Google Scholar
• Bruni L, Diaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010 Dec 15;202(12):1789–1799.
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Alemany L, Lacey C, et al. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F32–46.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
   PubMed Web of Science ®Google Scholar
• Ghittoni R, Accardi R, Chiocca S, et al. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015;9:526.
   PubMed Web of Science ®Google Scholar
• Subramanya D. Grivas PD. HPV and cervical cancer: updates on an established relationship. Postgrad Med. 2008;120(4):7–13.
   PubMed Web of Science ®Google Scholar
• Haedicke J, Iftner T. Human papillomaviruses and cancer. Radiother Oncol. 2013;108(3):397–402.
   PubMed Web of Science ®Google Scholar
• Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3):S3/35–41.
   PubMedGoogle Scholar
• Syrjanen SM. Syrjanen KJ. New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med. 1999;31:175–187.
   PubMed Web of Science ®Google Scholar
• Thomas M, Pim D, Banks L. The role of E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene. 1999;18:7690–7700.
   PubMed Web of Science ®Google Scholar
• Castellsagué X, Bosch FX, Muñoz N. Environmental co-factors in HPV carcinogenesis. Virus. Res. 2002;89(2):191–199.
   Google Scholar
• Muñoz N, Franceschi S, Bosetti C, et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093–1101.
   PubMed Web of Science ®Google Scholar
• Moreno V, Bosch FX, Muñoz N, et al. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 2002;359(9312):1085–1092.
   PubMed Web of Science ®Google Scholar
• De Sanjosé S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res. 2002;89(2):201–211.
   PubMed Web of Science ®Google Scholar
• Smith JS, Herrero R, Bosetti C, et al.; International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst. 2002 Nov 6;94(21):1604–1613.
   PubMedGoogle Scholar
• Parkin DM. The global burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–3044.
   PubMed Web of Science ®Google Scholar
• Castellsagué X, Diaz M, De Sanjosé S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Nat Cancer Inst. 2006;98(5):303.
   PubMed Web of Science ®Google Scholar
• Houlihan CF, Baisley K, Bravo IG, et al. The incidence of human papillomavirus in Tanzanian adolescent girls before reported sexual debut. J Adolesc Health. 2016;58(3):295–301.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917.
   PubMed Web of Science ®Google Scholar
• Msyamboza KP, Phiri T, Sichali W, et al. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study. BMC Public Health. 2016;16:806.
   PubMed Web of Science ®Google Scholar
• Louie KS, De Sanjose S, Mayaud P. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health. 2009;14(10):1287–1302.
   PubMed Web of Science ®Google Scholar
• McCarthy M, Maher D, Ly A, et al. Developing the agenda for European Union collaboration on non-communicable diseases research in sub-Saharan Africa. Health Res Policy Syst. 2010;8:13.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2008. The global burden of disease: 2004 update. Geneva: WHO. Last accessed April 21, 2016. Available at http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf?ua=1
   Google Scholar
• World health Organization, 2015. Projections of mortality and causes of death, 2015 and 2030. ( Last accessed October 2016). Available at: http://www.who.int/healthinfo/global_burden_disease/projections/en/
   Google Scholar
• Organisation Mondiale de la Santé, 2015: Estimations de la mortalité maternelle en 2015. [Estimation of maternal mortality in 2015] ( Last accessed September 2016). Available from: http://apps.who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf
   Google Scholar
• Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83(1):18–29.
   PubMed Web of Science ®Google Scholar
• Ogembo RK, Gona PN, Seymour AJ, et al. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. Plos One. 2015;10(4):e0122488.
   PubMed Web of Science ®Google Scholar
• Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006 Aug 31;24(Suppl 3):S3/71-7.
   PubMedGoogle Scholar
• Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927–935.
   PubMed Web of Science ®Google Scholar
• Watson-Jones D, Baisley K, Brown J, et al. High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects. Sex Transm Infect. 2013 Aug;89(5):358–365.
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Mndende XK, Kharsany AB, et al. High burden of human papillomavirus (HPV) infection among young women in KwaZulu-Natal, South Africa. Plos One. 2016;11(1):e0146603.
   PubMed Web of Science ®Google Scholar
• McDonald AC, Denny L, Wang C, et al. Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa. Plos One. 2012;7(9):e44332.
   Google Scholar
• Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, et al. HIV associated high-risk HPV infection among Nigerian women. BMC Infect Dis. 2013;13:521.
   PubMed Web of Science ®Google Scholar
• Boumba LM, Hilali L, Mouallif M, et al. Specific genotypes of human papillomavirus in 125 high-grade squamous lesions and invasive cervical cancer cases from Congolese women. BMC Public Health. 2014 Dec 23;14:1320.
   PubMed Web of Science ®Google Scholar
• Zoa Assoumou S, Ndjoyi Mbiguino A, Mabika Mabika B, et al. Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agent Cancer. 2016;11:2.
   PubMed Web of Science ®Google Scholar
• Moussavou PB, Koumakpayi IH, Nkili-Meyong AA, et al. Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon. Infect Agent Cancer. 2016;11(1):50.
   Google Scholar
• World Health Organization. 2015. HIV/AIDS Global situation and trends. WHO: 2015. [cited 2016 Oct 17]. Available from: http://www.who.int/gho/hiv/en/
   Google Scholar
• Mbulawa ZZ, Marais DJ, Johnson LF, et al. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women. J Infect Dis. 2012;206(1):15–27.
   PubMed Web of Science ®Google Scholar
• Centre for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep. 1993;41:1–5.
   Google Scholar
• De Vuyst H, Lillo F, Broutet N, et al. Human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008;17(6):545–554.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954–962.
   PubMed Web of Science ®Google Scholar
• Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt). 2012;21(10):1031–1037.
   PubMed Web of Science ®Google Scholar
• Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. Plos Med. 2008;5(6):e132.
   PubMed Web of Science ®Google Scholar
• Sherris J, Wittet S, Kleine A, et al. Evidence-based, alternative cervical cancer screening approaches in low-resource settings. Int Perspect Sex Reprod Health. 2009;35(3):147–154.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Sitas F, Chirenje M, et al. Cancer in indigenous Africans – burden, distribution, and trends. Lancet Oncol. 2008;9(7):683–692.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(Suppl 2):S4–S12.
   PubMed Web of Science ®Google Scholar
• Adefuye PO, Broutet NJ, de Sanjosé S, Denny LA. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F53–9.
   Google Scholar
• Arbyn M, Sankaranarayanan R, Muwonge R, et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer. 2008;123(1):153–160.
   PubMed Web of Science ®Google Scholar
• Fokom-Domgue J, Combescure C, Fokom-Defo V, et al. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. Bmj. 2015;351:h3084.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Bergeron C, von Knebel Doeberitz M, et al. New technologies and procedures for cervical cancer screening. Vaccine. 2012;30(Suppl 5):F107–16.
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R, Basu P, Wesley RS, et al. IARC Multicentre Study Group on Cervical Cancer Early Detection. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110(6):907–913.
   PubMed Web of Science ®Google Scholar
• Denny L, Herrero R, Levin C, et al. Source Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov. Chapter 4.
   Google Scholar
• Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008;9(10):929–936.
   PubMed Web of Science ®Google Scholar
• Wang SM, Hu SY, Chen W, et al. Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening. BMC Cancer. 2015;15:848.
   PubMed Web of Science ®Google Scholar
• Cubie HA, Morton D, Kawonga E, et al. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert® HPV assay. J Clin Virol. 2016;87:1–4.
   PubMed Web of Science ®Google Scholar
• Segondy M, Kelly H, Magooa MP, et al.; HARP Study Group. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP Study. Brit J Cancer. 2016;115:425–430.
   PubMed Web of Science ®Google Scholar
• Bansil P, Wittet S, Lim JL, et al. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14:596.
   PubMed Web of Science ®Google Scholar
• Origoni M, Cristoforoni P, Carminati G, et al. E6/E7 mRNA testing for human papillomavirus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. Ecancermedicalscience. 2015;9:533.
   PubMed Web of Science ®Google Scholar
• Johansson H, Bielkenkrantz K, Darlin L, et al. Presence of high-risk HPV mRNA in relation to future high-grade lesions among high-risk HPV DNA positive women with minor cytological abnormalities. Plos One. 2015;10(4):e0124460.
   Google Scholar
• Basu P, Banerjee D, Mittal S, et al. Sensitivity of APTIMA HPV E6/E7 mRNA test in comparison with hybrid capture 2 HPV DNA test for detection of high risk oncogenic human papillomavirus in 396 biopsy confirmed cervical cancers. J Med Virol. 2016;88(7):1271–1278.
   PubMed Web of Science ®Google Scholar
• Adamson PC, Huchko MJ, Moss AM, et al. Acceptability and accuracy of cervical cancer screening using self-collected tampon for HPV messenger-RNA testing among HIV-infected women in South Africa. Plos One. 2015;10(9):e0137299.
   Google Scholar
• Shi JF, Chen JF, Canfell K, et al. Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study. BMC Healt Serv Res. 2012;12:13.
   PubMed Web of Science ®Google Scholar
• Cepheid. Eligible countries for Cepheid’s HBDC pricing/Global access program. 2016. (last accessed 12 April, 2017). Available from: https://www.finddx.org/find-negociated-product-pricing/
   Google Scholar
• United Nations General Assembly High-Level Meeting on Ending AIDS. Political Declaration on HIV and AIDS. ( Last accessed October 17, 2016). Available from: http://pinkribbonredribbon.org/wp-content/uploads/2016/09/2016-UN-HLM-political-declaration-HIV-AIDS.pdf
   Google Scholar
• UNAIDS 2016 |REFERENCE. HPV, HIV and cervical cancer. Leveraging synergies to save women’s lives. UNAIDS Joint United Nations Programme on HIV/AIDS, 2016. ( Last accessed October 17, 2016). Available from: http://www.unaids.org/sites/default/files/media_asset/JC2851_HPV-HIV-cervicalcancer_en.pdf
   Google Scholar
• Williamson AL. The interaction between human immunodeficiency virus and human papillomaviruses in heterosexuals in Africa. J Clin Med. 2015;4(4):579–592.
   PubMed Web of Science ®Google Scholar
• Huchko MJ, Maloba M, Nakalembe M, et al. The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. J Int AIDS Soc. 2015;18(Suppl 5):20282.
   PubMedGoogle Scholar
• World health organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2030. 2013. (Last accessed November 1st, 2016). Available at: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf?ua=1
   Google Scholar
• World Health Organization. 2012. Implementing comprehensive HIV/STI programmes with sex workers. Practical approaches from collaborative interventions. Geneva: World Health Organization, UNAIDS. Last accessed September, 2016. Available at http://apps.who.int/iris/bitstream/10665/96614/1/WHO_HIV_2013.144_eng.pdf
   Google Scholar
• Dhana A, Luchters S, Moore L, et al. Systematic review of facility-based sexual and reproductive health services for female sex workers in Africa. Global Health. 2014;10:46.
   PubMed Web of Science ®Google Scholar
• Kelly HA, Sawadogo B, Chikandiwa A, et al. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy. Aids. 2017;31(2):273–285.
   PubMed Web of Science ®Google Scholar
• Organisation Mondiale de la Santé, 2014. Lignes directrices de l’OMS. Lignes directrices de l’OMS pour le dépistage et le traitement des lésions précancéreuses pour la prévention du cancer du col de l’utérus. Geneva: WHO. [cited 2016 Nov]. Available from: http://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/fr/
   Google Scholar
• World health Organization. Human papillomavirus vaccines: WHO position paper. 2014. Vol. 89, 43(pp. 465–492). Geneva: WHO. [cited 2016 Nov]. Available from: http://www.who.int/wer/2014/wer8943/en/
   Google Scholar
• Lu B, Kumar A, Castellsagué X, et al. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.
   PubMed Web of Science ®Google Scholar
• Denny L, Adewole I, Anorlu R, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;134(6):1389–1398.
   PubMed Web of Science ®Google Scholar
• Jenkins M, Chiriva-Internati M, Mirandola L, et al. Perspective for prophylaxis and treatment of cervical cancer: an immunological approach. Int Rev Immunol. 2012;31(1):3–21.
   PubMed Web of Science ®Google Scholar
• Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30(Suppl 5):F123–38.
   PubMed Web of Science ®Google Scholar
• Garland SM, Smith JS. Human papillomavirus vaccines: current status and future prospects. Drugs. 2010;70(9):1079–1098.
   PubMed Web of Science ®Google Scholar
• Binagwaho A, Ngabo F, Wagner CM, et al. Integration of comprehensive women’s health programmes into health systems: cervical cancer prevention, care and control in Rwanda. Bull World Health Organ. 2013;91(9):697–703.
   PubMed Web of Science ®Google Scholar
• Cervical Cancer Action (CCA 2016). Global progress in HPV vaccination. Status: November 2016. (Last accession: 21 December 2016). Available at: www.cervicalcanceraction.org/comments/comments3.php
   Google Scholar
• Binagwaho A, Wagner CM, Gatera M, et al. Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme. Bull World Health Organ. 2012;90(8):623–628.
   PubMed Web of Science ®Google Scholar
• GAVI (2011). GAVI welcomes lower prices for life-saving vaccines. ( Last accessed November 2016). Available at: www.gavi.org/library/news/press-releases/2011/gavi-welcomes-lower-prices-for-life-saving-vaccines/
   Google Scholar
• Pelman S, Wamai RG, Bain PA, et al. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. Plos ONE. 2014;9(3):e90912.
   Google Scholar
• Cunningham MS, Davison C, Aronson KJ. HPV vaccine acceptability in Africa: a systematic review. Prev Med. 2014;69:274–279.
   PubMed Web of Science ®Google Scholar
• Botha MH, van der Merwe FH, Snyman LC, et al. The vaccine and cervical cancer screen (VACCS) project: acceptance of human papillomavirus vaccination in a school-based programme in two provinces of South Africa. S Afr Med J. 2015;105(1):40–43.
   PubMed Web of Science ®Google Scholar
• Mugisha E, LaMontagne DS, Katahoire AR, et al. Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda. Afr Health Sci. 2015;15(1):33–41.
   PubMed Web of Science ®Google Scholar
• LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011;89(11):821–830B.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Campos NG, O’Shea M, et al. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F60–72.
   Google Scholar
• Ladner J, Besson MH, Audureau E, et al. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014. BMC Health Serv Res. 2016;16(1):575.
   PubMed Web of Science ®Google Scholar
• Denny L, Hendricks B, Gordon C, et al. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomized placebo-controlled study. Vaccine. 2013;31(48):5745–5753.
   PubMed Web of Science ®Google Scholar
• Kahn JA, Xu J, Kapogiannis BG, et al. Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis. 2013;57(5):735–744.
   PubMed Web of Science ®Google Scholar
• Sow PS, Watson-Jones D, Kiviat N. Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine: a randomized trial in 10-25-year-old HIV-Seronegative African girls and young women. J Infect Dis. 2013;207(11):1753–1763.
   PubMed Web of Science ®Google Scholar
• Kreimer AR, Struyf F, Del Rosario-Raymundo MR, et al. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. Lancet Oncol. 2015;16(7):775–786.
   PubMed Web of Science ®Google Scholar
• Arya J, Prausnitz MR. Microneedle patches for vaccination in developing countries. J Control Release. 2016;240:135–141.
   PubMed Web of Science ®Google Scholar
• van Damme P, Olsson SE, Block S, et al. Immunogenicity and safety of a 9-Valent HPV vaccine. Pediatrics. 2015;136(1):e28–39.
   PubMed Web of Science ®Google Scholar
• Kiatpongsan S, Kim JJ. Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries. Plos One. 2014;9(9):e106836.
   PubMed Web of Science ®Google Scholar
• Berthet N, Berling C, Nabi H, et al. COFAC-Col: a cervical cancer control networking initiative in five French-speaking African countries. Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):1004–1005.
   PubMed Web of Science ®Google Scholar
• WAKA HPV Africa. (Afrique du Sud, Burundi, Ethiopie, Kenya Ouganda, République Démocratique du Congo, Tanzanie, Zambie). Available at: https://www.uantwerpen.be/en/projects/waka-hpv-africa/
   Google Scholar
• Pink Ribbon/Red Ribbon. 2015. Pink Ribbon Red Ribbon and World Vision Join Forces to Fight Women’s Cancer in Sub-Saharan Africa. PINKREDRIBBON, 2015. [cited 2017 Apr]. Available at : http://pinkribbonredribbon.org/pink-ribbon-red-ribbon-and-world-vision-join-forces-to-fight-womens-cancer-in-sub-saharan-africa/
   Google Scholar
• Organisation Mondiale de la Santé. Le cancer du col de l’utérus dans la région Africaine de l’OMS: Situation actuelle et perspectives. Comité régional de l’Afrique. Soixantième session. Malabo: Guinée équatoriale; 2010. Cervical cancer in the African Region of WHO: current situation and perspectives. Regional Committee for Africa. Sixtieth session. Malabo, Equatorial Guinea, 2010. Last accessed September 2016. Available at http://apps.who.int/iris/bitstream/10665/1730/1/afr_rc60_6_fr%5b1%5d.pdf
   Google Scholar
• Goldie SJ, Weinstein MC, Kuntz KM, et al. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med. 1999;130(2):97–107.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Comprehensive cervical cancer control: guide to essential practice – 2nd Ed. Geneva: WHO. 2014. [cited 2017 Apr 12]. Available from: http://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/
   Google Scholar
• Garland SM, Kjaer SK, Munoz N, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis? 2016;63(4):519–527.
   PubMed Web of Science ®Google Scholar
• UN General Assembly. Vol. A/66/L.1: UN.2011. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases. (last accessed 12 April, 2017) Available at: www.who.int/nmh/events/un_ncd_summit2011/polical_declaration_en_pdf
   Google Scholar
• World Health Organization. 2015. UN Sustainable Development Summit 2015: Sustainable Development Goals. 25-7. September 2015. UN HQ, New York City, United States of America. WHO. 2015. [cited 2017 Apr 12]. Available from: http://www.who.int/mediacentre/events/meetings/2015/un-sustainable-development-summit/en/
   Google Scholar